Suppr超能文献

多发性骨髓瘤患者心律失常的发生率及其预后价值

Incidence of Arrhythmias and Their Prognostic Value in Patients With Multiple Myeloma.

作者信息

Li Yongxin, Tang Manyun, Zhong Liang, Wei Suhua, Song Jingzhuo, Liu Hui, Sun Chaofeng, Wang Jie

机构信息

Department of Cardiovascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

出版信息

Front Cardiovasc Med. 2021 Nov 15;8:753918. doi: 10.3389/fcvm.2021.753918. eCollection 2021.

Abstract

Arrhythmias are common cardiovascular complications in multiple myeloma (MM) patients and are related to a poor prognosis. This study aimed to assess the burden of arrhythmias and their prognostic value in patients with MM. This was a retrospective study of patients with MM between January 2015 and April 2020 at the First Affiliated Hospital of Xi'an Jiaotong University. The incidence of arrhythmia and associated risk factors were evaluated. The relationship between the type of arrhythmia and survival was analyzed. A total of 319 patients with MM were identified, and 48.0% (153/319) had arrhythmias. The most common type of arrhythmia was sinus tachycardia (ST) (15.0%, 48/319), followed by sinus bradycardia (SB) (14.4%, 46/319), premature atrial contractions (PACs) (6.3%, 20/319), conduction disorders (CDs) (6.0%, 19/319), atrial fibrillation (AF) (6.0%, 19/319), premature ventricular contractions (PVCs) (4.4%, 14/319) and paroxysmal supraventricular tachycardia (PSVT) (0.6%, 2/319). The patients with arrhythmias had higher levels of log NT-proBNP and creatinine, greater bortezomib use, and a higher incidence of diabetes than those without arrhythmias ( < 0.05). The all-cause mortality rates of patients without arrhythmias and those with AF, ST, PACs, CDs, SB, and PVCs were 50.6% (84/166), 73.7% (14/19), 60.4% (29/48), 60.0% (12/20), 52.6% (10/19), 34.8% (16/46), and 28.6% (4/14), respectively. In a subgroup analysis of patients experiencing different types of arrhythmias, patients with SB had lower all-cause mortality than patients with AF ( < 0.01). Univariate and multivariate Cox analyses showed that there was a positive statistically significant association between SB and survival (HR: 0.592 [0.352-0.998], = 0.049) in a subgroup analysis of different arrhythmias. Patients with MM had a heavy arrhythmia burden, and in this study, approximately half of MM patients had arrhythmias. MM patients with SB were associated with lower all-cause mortality than those with AF. SB might be an independent positive factor for prognosis.

摘要

心律失常是多发性骨髓瘤(MM)患者常见的心血管并发症,且与预后不良相关。本研究旨在评估MM患者心律失常的负担及其预后价值。这是一项对2015年1月至2020年4月在西安交通大学第一附属医院就诊的MM患者的回顾性研究。评估了心律失常的发生率及相关危险因素。分析了心律失常类型与生存之间的关系。共纳入319例MM患者,其中48.0%(153/319)发生心律失常。最常见的心律失常类型是窦性心动过速(ST)(15.0%,48/319),其次是窦性心动过缓(SB)(14.4%,46/319)、房性早搏(PACs)(6.3%,20/319)、传导障碍(CDs)(6.0%,19/319)、心房颤动(AF)(6.0%,19/319)、室性早搏(PVCs)(4.4%,14/319)和阵发性室上性心动过速(PSVT)(0.6%,2/319)。与无心律失常的患者相比,心律失常患者的log NT-proBNP和肌酐水平更高,硼替佐米使用量更大,糖尿病发病率更高(P<0.05)。无心律失常患者、AF患者、ST患者、PACs患者、CDs患者、SB患者和PVCs患者的全因死亡率分别为50.6%(84/166)、73.7%(14/19)、60.4%(29/48)、60.0%(12/20)、52.6%(10/19)、34.8%(16/46)和28.6%(4/14)。在不同类型心律失常患者的亚组分析中,SB患者的全因死亡率低于AF患者(P<0.01)。单因素和多因素Cox分析显示,在不同心律失常的亚组分析中,SB与生存之间存在统计学上的正相关(HR:0.592[0.352 - 0.998],P = 0.049)。MM患者心律失常负担较重,在本研究中,约一半的MM患者发生心律失常。与AF患者相比,伴有SB的MM患者全因死亡率较低。SB可能是一个独立的预后积极因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a78/8634844/8115868e4911/fcvm-08-753918-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验